Bio-Techne Corporation (TECH)

NASDAQ: TECH · USD

$72.7

+0.09 (+0.1%)· Recorded snapshot

Market cap	11.4B
Revenue (ttm)	1.2B
Net income (ttm)	181.8M
EPS (ttm)	$1.16
Shares out	156.8M
P/E (trailing)	62.7x
P/E (forward)	35.7x
Dividend	$0.32 (0.44%)
Volume	2,319,141
Beta	1.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): 181.8M
EPS (ttm): $1.16
P/E (trailing): 62.7x
P/E (forward): 35.7x
Market cap: 11.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E35.7

P25 n/aP50 n/aP75 n/a

Trailing P/E62.7

P25 n/aP50 n/aP75 n/a

ROE9

P25 n/aP50 n/aP75 n/a

ROIC9.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TECH indicators

Market & fundamental data

Available fields

287

Groups with data

Currency

USD

Showing 287 of 287 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000842023
Company name	Bio-Techne Corporation
Country	United States
Country code	US
CUSIP number	09073M104
Earnings date	2026-11-09
Earnings time	bmo
Employees	3,000
Employees change	-100
Employees growth	-3.23%
Enterprise value	$11.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	1976
In index	SP500
Industry	Biotechnology
IPO date	1989-02-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US09073M1045
Last 10-K release date	2026-08-24
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2022-11-30
Last stock split type	Forward
Market cap	$11.4B
Market cap category	Large-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$72.69
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	TECH
U.S. state	Minnesota
Website	https://www.bio-techne.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	37.66x
Average P/E ratio (10Y)	64.95x
Average P/E ratio (3Y)	76.34x
Average P/E ratio (5Y)	71.09x
Earnings yield	1.6%
EV/Earnings	62.79x
EV/EBIT	41.59x
EV/EBITDA	34.17x
EV/FCF	43.38x
EV/Sales	9.4x
FCF / EV yield	2.31%
FCF yield	2.31%
Forward EV/Sales	9.03x
Forward P/E	35.66x
Forward P/S	9.02x
Graham number	18.77516
Graham upside	-74.16%
Lynch fair value	$6.17
Lynch upside	-91.51%
P/(FCF - SBC) ratio	51.36x
P/(OCF - SBC) ratio	45.45x
P/B ratio	5.38x
P/E ratio	62.66x
P/FCF ratio	43.29x
P/OCF ratio	39.01x
P/S ratio	9.38x
Price / tangible book value	13.74x
Price/EBITDA ratio	34.1x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	22.6%
EBITDA margin	27.5%
Effective tax rate	24.44%
FCF margin	21.66%
Gross margin	66.24%
Operating margin	22.6%
Pretax margin	19.81%
Profit margin	14.97%
Profit per employee	$60,613
Profitable quarters	4
Profitable years	34
Revenue per employee	$405,013
ROA	6.67%
ROA (5Y)	6.51%
ROCE	11.33%
ROE	9.03%
ROE (5Y)	10.54%
ROIC	9.66%
ROIC (5Y)	10.48%
SBC / revenue	3.4%
Tax / revenue	4.84%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	152.17%
EPS growth (QoQ)	9.39%
EPS growth 10Y	5.18%
EPS growth 3Y	-12.97%
EPS growth 5Y	5.92%
EPS growth quarters	4
EPS growth years	1
FCF growth	2.6%
FCF growth (Q)	-6.83%
FCF growth (QoQ)	12.07%
FCF growth 3Y	6.79%
FCF growth 5Y	-3.08%
Gross profit growth	-0.77%
Gross profit growth (Q)	0.43%
Gross profit growth 3Y	1.48%
Gross profit growth 5Y	4.87%
Net income growth	147.77%
Net income growth (QoQ)	7.06%
Net income growth 3Y	-13.93%
Net income growth 5Y	5.32%
Net income growth quarters	4
Net income growth years	1
OCF growth	1.57%
OCF growth (Q)	-2.84%
OCF growth (QoQ)	10.1%
OCF growth 10Y	7.32%
OCF growth 3Y	4.71%
OCF growth 5Y	-3.67%
Operating income growth	22.89%
Operating income growth (Q)	8.03%
Operating income growth 3Y	-0.78%
Operating income growth 5Y	1.78%
Revenue growth	-0.38%
Revenue growth (Q)	1.33%
Revenue growth (QoQ)	3.14%
Revenue growth 10Y	9.31%
Revenue growth 3Y	2.25%
Revenue growth 5Y	5.47%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-28.9M
Depreciation and amortization	$59.6M
EBIT	$274.5M
EBITDA	$334.1M
EPS	$1.16
FCF per share	$1.68
Financing cash flow	$-169.1M
Free cash flow	$263.2M
Free cash flow minus SBC	$221.9M
Gross profit	$804.9M
Income taxes	$58.8M
Investing cash flow	$-18.2M
Net borrowing	$-146M
Net cash flow	$102.5M
Net income	$181.8M
Operating cash flow minus SBC	$250.7M
Operating income	$274.5M
Revenue	$1.2B
Stock-based compensation	$41.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	12.89
Book value per share	$13.51
Debt / EBITDA	0.81
Debt / equity	0.14
Debt / FCF	1.1
Goodwill	$975.4M
Interest coverage	28.51
Long-term assets	$1.8B
Long-term liabilities	$314.8M
Net cash (debt)	$-23.6M
Net cash / market cap	-0.21%
Net debt / EBITDA	0.07
Net debt / equity	0.01
Net debt / FCF	0.09
Piotroski F-Score	7
Property, plant and equipment	$299.2M
Shareholders' equity	$2.1B
Tangible book value	$829.4M
Tangible book value per share	$5.31
Total assets	$2.6B
Total cash	$265.5M
Total debt	$289.1M
Total liabilities	$478.5M
WACC	11.15%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	$744.4M
Current liabilities	$163.7M
Current ratio	4.55
Inventory turnover	2.13
Net working capital	$330.2M
Quick ratio	2.94
Working capital	$580.7M
Working capital turnover	2.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.7%
Dividend growth	0%
Dividend growth (10Y)	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-09-04
Dividend payment years	19
Dividend payout frequency	Quarterly
Dividend per share	$0.32
Dividend yield	0.44%
Ex-dividend date	2026-08-24
FCF payout ratio	19.06%
Last dividend	$0.08
Payout ratio	27.59%
Shareholder yield	2.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	187.1%
10Y return CAGR	11.78%
10Y total return	204.58%
150-day SMA	$64.11
15Y price change	312.95%
15Y return CAGR	10.9%
15Y total return	371.93%
1D price change	0.12%
1M price change	0.03%
1M total return	0.03%
1W price change	0.07%
1W total return	0.07%
1Y price change	13.04%
1Y return CAGR	13.69%
1Y total return	13.68%
20-day SMA	$72.53
200-day SMA	$63.10
20Y price change	420.72%
20Y return CAGR	9.6%
20Y total return	524.98%
3M price change	1.41%
3M total return	1.52%
3Y price change	21.99%
3Y return CAGR	7.41%
3Y total return	23.91%
50-day SMA	$72.44
50-day SMA vs 200-day SMA	50over200
52-week high	$72.75
52-week high date	2026-10-27
52-week low	$43.20
52-week low date	2026-05-15
5Y price change	-43.01%
5Y return CAGR	-10.23%
5Y total return	-41.69%
6M price change	31.79%
6M total return	32.18%
All-time high	$135.96
All-time high date	2021-09-23
All-time low	$0.55
All-time low date	1994-08-03
Average true range (ATR)	$0.15
Average volume	2.7M
Beta (1Y)	0.58
Beta (2Y)	0.8
Beta (5Y)	1.3
Change from 52-week high	-0.09%
Change from 52-week low	68.27%
Change from all-time high	-46.58%
Change from all-time low	13,180.31%
Change from open	0.06%
Day's gap	0.06%
Dollar volume	$168.6M
High price	$72.72
Low price	$72.62
Monthly RSI	56.08
Open price	$72.64
Position in 52-week range	65%
Premarket change	-1.04%
Premarket close	$72.60
Premarket price	$71.85
Previous close	$72.60
Price vs 150-day SMA	13.29%
Price vs 20-day SMA	0.13%
Price vs 200-day SMA	15.1%
Price vs 50-day SMA	0.27%
Relative volume	0.85
RSI	57.04
Sharpe ratio	0.42
Sharpe ratio (3Y)	0.23
Sharpe ratio (5Y)	-0.18
Sortino ratio	0.77
Sortino ratio (3Y)	0.49
Sortino ratio (5Y)	-0.11
Volume	2.3M
Weekly RSI	64.43
YTD price change	23.5%
YTD total return	24.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	156.1M
Float percentage	99.57%
Shares change (QoQ)	-0.24%
Shares change (YoY)	-1.7%
Shares held by insiders	0.35%
Shares held by institutions	113.04%
Shares outstanding	156.8M
Short % of float	4.73%
Short % of shares	4.71%
Short ratio	2.4 days

Deeper analysis on TECH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TECH report

Is a complete TECH research report available?

No complete published report is available for Bio-Techne Corporation (TECH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Bio-Techne Corporation (TECH)

Price

Financial snapshot

Fair-value bridge

Latest news · TECH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TECH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TECH

Frequently asked questions